Enjoy complimentary customisation on priority with our Enterprise License!
The cardiac restoration systems market share is expected to increase to USD 138.68 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.25%.
This cardiac restoration systems market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers cardiac restoration systems market segmentation by product (mitral valve restoration systems and left ventricular restoration systems), end-user (hospitals, ASCs, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). The cardiac restoration systems market report also offers information on several market vendors, including Abbott Laboratories, Ancora Heart Inc., Artivion Inc., BioVentrix Inc., Edwards Lifesciences Corp., Medtronic Plc, NeoChord Inc., and Xeltis AG among others.
Download the Free Report Sample to Unlock the Cardiac Restoration Systems Market Size for the Forecast Period and Other Important Statistics
Technavio categorizes the global cardiac restoration systems market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the cardiac restoration systems market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the cardiac restoration systems market encompasses successful business strategies deployed by the key vendors. The cardiac restoration systems market is concentrated and the vendors are deploying growth strategies such as organizing campaigns and programs to educate patients about the importance of early diagnosis and treatment using cardiac restoration systems to compete in the market.
abbott.com - The company offers a cardiac restoration systems such as Mitraclip Transcatheter Mitral Valve Repair that delivers a minimally invasive treatment option for patients with primary or secondary mitral regurgitation.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The cardiac restoration systems market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the cardiac restoration systems market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
37% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for cardiac restoration systems in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.
The presence of well-equipped and established healthcare infrastructure, the availability of highly skilled professionals, and the presence of extensive healthcare insurance coverage will facilitate the cardiac restoration systems market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 in 2020 negatively impacted the regional cardiac restoration systems market. This is primarily attributed to the imposition of nationwide lockdowns by regional governments to control the spread of the virus. The demand for different types of diagnostics equipment and cardiac restoration systems witnessed a significant increase as the number of COVID-19 patients in hospitals surged in 2020. Thus, the market in focus was accelerated in 2020. From the Q4 of 2020, the market started regaining its momentum due to the numerous regional government initiatives such as an increase in the investment in healthcare infrastructure.
To gain further insights on the market contribution of various segments Request for a FREE sample
The cardiac restoration systems market share growth by the mitral valve restoration systems segment will be significant during the forecast period. Mitral valve restoration systems are effective over conventional heart valve repair devices in assisting, restoring, and tethering valve leaflets. The present trend in the market is the development of mitral valve restoration devices using tissue engineering approaches.
This report provides an accurate prediction of the contribution of all the segments to the growth of the cardiac restoration systems market size and actionable market insights on post COVID-19 impact on each segment.
The increasing prevalence of CVDs is notably driving the cardiac restoration systems market growth, although factors such as the availability of alternatives may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the cardiac restoration systems industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Cardiac Restoration Systems Market Driver
Key Cardiac Restoration Systems Market Trend
Key Cardiac Restoration Systems Market Challenge
This cardiac restoration systems market analysis report also provides actionable insights on the trends and challenges that will help companies evaluate and develop growth strategies for 2022-2026.
|
Cardiac Restoration Systems Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.25% |
|
Market growth 2022-2026 |
$ 138.68 million |
|
Market structure |
Concentrated |
|
YoY growth (%) |
5.15 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 37% |
|
Key consumer countries |
US, Canada, Denmark, China, and India |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
Abbott Laboratories, Ancora Heart Inc., Artivion Inc., BioVentrix Inc., Edwards Lifesciences Corp., Medtronic Plc, NeoChord Inc., and Xeltis AG |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Market Segmentation by End-user
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
